| Unique ID issued by UMIN | UMIN000060925 |
|---|---|
| Receipt number | R000069659 |
| Scientific Title | Efficacy and safety of imeglimin in Japanese patients with type 2 diabetes |
| Date of disclosure of the study information | 2026/04/01 |
| Last modified on | 2026/03/13 14:44:56 |
Efficacy and safety of imeglimin in Japanese patients with type 2 diabetes
East Shizuoka Imeglimin study
Efficacy and safety of imeglimin in Japanese patients with type 2 diabetes
East Shizuoka Imeglimin study
| Japan |
Type 2 diabetes
| Endocrinology and Metabolism |
Others
NO
To examine efficacy and safety of imeglimin in Japanese patients with type 2 diabetes in real world clinical state
Efficacy
Confirmatory
Pragmatic
Not applicable
Glycemic control(HbA1c)
Observational
| 18 | years-old | <= |
| 85 | years-old | >= |
Male and Female
Type 2 diabetes
Type 1 diabetes
300
| 1st name | Takashi |
| Middle name | |
| Last name | Nomiyama |
Juntendo university Shizuoka hospital
Department of Diabetes, Endocrinology and Metabolism
410-2295
1129 Nagaoka, Izunokunishi, Shizuoka, Japan
0559483111
nomiyama@juntendo.ac.jp
| 1st name | Takashi |
| Middle name | |
| Last name | Nomiyama |
Juntendo university Shizuoka hospital
Department of Diabetes, Endocrinology and Metabolism
410-2295
1129 Nagaoka, Izunokunishi, Shizuoka, Japan
08068120818
nomiyama@juntendo.ac.jp
Juntendo university
None
Self funding
Research Ethics Committee Faculty of Medicine, Juntendo University
1129 Nagaoka, Izunokunishi
055-948-3111
tkuematu@juntendo.ac.jp
NO
| 2026 | Year | 04 | Month | 01 | Day |
Unpublished
Open public recruiting
| 2026 | Year | 02 | Month | 04 | Day |
| 2026 | Year | 03 | Month | 06 | Day |
| 2026 | Year | 03 | Month | 06 | Day |
| 2026 | Year | 08 | Month | 31 | Day |
None
| 2026 | Year | 03 | Month | 13 | Day |
| 2026 | Year | 03 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069659